Teladoc HealthTDOC
TDOC
About: Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Employees: 5,500
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
38% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 55
13% more call options, than puts
Call options by funds: $65.6M | Put options by funds: $58.3M
11% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 100
4% more funds holding
Funds holding: 358 [Q3] → 373 (+15) [Q4]
0.36% more ownership
Funds ownership: 73.22% [Q3] → 73.58% (+0.36%) [Q4]
0% more capital invested
Capital invested by funds: $1.15B [Q3] → $1.15B (+$2.14M) [Q4]
100% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$8
11%
upside
Avg. target
$9.95
38%
upside
High target
$13
81%
upside
5 analyst ratings
2 positive
40%
3 neutral
60%
0 negative
0%
Citigroup Daniel Grosslight 40% 1-year accuracy 10 / 25 met price target | 22%upside $8.75 | Neutral Maintained | 25 Apr 2025 |
Jefferies Glen Santangelo 45% 1-year accuracy 5 / 11 met price target | 11%upside $8 | Hold Maintained | 21 Apr 2025 |
B of A Securities Allen Lutz 69% 1-year accuracy 11 / 16 met price target | 11%upside $8 | Neutral Maintained | 11 Apr 2025 |
Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target | 81%upside $13 | Buy Maintained | 3 Mar 2025 |
Piper Sandler Jessica Tassan 26% 1-year accuracy 6 / 23 met price target | 67%upside $12 | Overweight Maintained | 27 Feb 2025 |
Financial journalist opinion
Based on 10 articles about TDOC published over the past 30 days
Neutral
GlobeNewsWire
3 hours ago
Teladoc Health Reports First Quarter 2025 Results
PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 (“First Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 (“First Quarter 2024”).
Neutral
CNBC
3 hours ago
Teladoc buys mental health company UpLift to help boost struggling BetterHelp unit
Teladoc Health has acquired mental health company UpLift for $30 million in cash. UpLift offers virtual mental health therapy, psychiatry and medication management services.
Neutral
GlobeNewsWire
3 hours ago
Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits
Teladoc Health has acquired UpLift, a virtual mental health provider with in-network health plan relationships representing more than 100M covered lives.
Positive
Zacks Investment Research
5 hours ago
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?
Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their platforms. Which one is a better investment?
Negative
Invezz
1 day ago
Teladoc stock forms a giant double bottom: will it rise after earnings?
Teladoc Health stock price continues to crash and is hovering at its lowest level on record ahead of its first-quarter earnings. It was trading at $7.16 on Monday, meaning that it has crashed by 21% this year and 46% in the last 12 months.
Positive
Zacks Investment Research
2 days ago
Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Teladoc (TDOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Negative
Zacks Investment Research
5 days ago
Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why
Teladoc (TDOC) concluded the recent trading session at $7.20, signifying a -0.83% move from its prior day's close.
Negative
Seeking Alpha
2 weeks ago
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade)
Teladoc Health, Inc.'s stock has declined significantly, from a high of $14 per share in February to $7 per share, with ongoing financial struggles and underperformance in key segments. The company reported a net loss of $1 billion in 2024, with declining revenues in its BetterHelp segment and minimal growth in Integrated Care. Despite efforts to cut costs and new initiatives like the Catapult Health acquisition and a partnership with Eli Lilly, Teladoc's value proposition remains unclear.
Negative
The Motley Fool
2 weeks ago
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to avoid those companies that only look undervalued but actually aren't.
Neutral
GlobeNewsWire
3 weeks ago
Teladoc Health Introduces Next Generation Cardiometabolic Health Program
PURCHASE, NY, April 08, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity. Building on the company's industry-leading chronic condition management programs, the new offering is designed to support optimal cardiometabolic health for all populations.
Charts implemented using Lightweight Charts™